- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on May 9, 2022
B-IRILENSA3IRILENS GOCCE OCULARI is an MDD-legacy medical device registered in EUDAMED. It is classified as Class IIb. Manufactured by MONTEFARMACO OTC SPA. Placed on the EU market in Italy. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
D-IRILENSA301675D-IRILENSA3
DataMatrix generation currently supports GS1-issued UDIs. HIBCC / ICCBBA support is coming.
European Medical Device Nomenclature — the EU product classification assigned to this device.
Q0299OPHTHALMIC DEVICES - OTHER3 warnings recorded — scroll inside the panel to see all entries.
• Lasciar trascorrere almeno 15 minuti dopo l’uso prima di istillare farmaci per uso oftalmico esterno. • Durante l’applicazione non toccare l’occhio né alcuna altra superficie con l’estremità di erogazione del monodose. • Non usare in caso di nota incompatibilità verso qualsiasi componente della preparazione. • Non usare il prodotto dopo la data di scadenza indicata sulla confezione. • Non disperdere il contenitore nell’ambiente dopo l’uso. In alcuni casi, dopo la somministrazione, si è osservato un breve offuscamento della vista dovuto alla densità della soluzione, che comunque scompare molto rapidamente.
Primary placement in Italy; available across 1 country total.
| Country | On market since | Until |
|---|---|---|
| ItalyPrimary placement | May 29, 2019 | May 26, 2024 |
IT-MF-0000133092019/MDDSterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
View in glossary →Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
View in glossary →Contains latex
A "contains latex" flag warns that a device contains natural rubber latex, which can trigger allergic reactions in sensitive patients.
View in glossary →CMR substance
A CMR flag warns that a device contains a substance that is carcinogenic, mutagenic or toxic to reproduction above a defined threshold.
View in glossary →Endocrine-disrupting substance
An endocrine-disruptor flag warns that a device contains a substance with endocrine-disrupting properties above a defined threshold.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
View in glossary →UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
View in glossary →MDR risk classes
MDR risk classes rank medical devices from lowest risk (Class I) to highest (Class III), which determines how much regulatory scrutiny they face.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →No certificate specifically references this device's Basic UDI-DI.
No certificates registered for this manufacturer.
No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.